COVID-19 Delayed Cancer Treatment, Diagnoses
Restrictions in access to care during the COVID-19 pandemic caused disruptions in the treatment and diagnoses of cancer and other conditions.
Read MorePosted by Andy Lundin | Dec 6, 2021 | Cancer, Covid 19 |
Restrictions in access to care during the COVID-19 pandemic caused disruptions in the treatment and diagnoses of cancer and other conditions.
Read MorePosted by Andy Lundin | Dec 3, 2021 | Covid 19, Rapid Assays |
The LumiraDx SARS-CoV-2 RNA STAR Complete has been authorized by FDA for emergency use under an EUA for use by authorized laboratories.
Read MorePosted by Andy Lundin | Dec 2, 2021 | Covid 19, Immunoassay Reagents & test Kits |
BD published a statement clarifying the efficacy of its rapid antigen and PCR tests to monitor for the COVID-19 Omicron variant.
Read MorePosted by Andy Lundin | Dec 2, 2021 | Covid 19, Immunoassay Reagents & test Kits |
Hologic designed its assays with the expectation that SARS-CoV-2 would continue to evolve, which is the natural path for viruses.
Read MorePosted by Andy Lundin | Dec 1, 2021 | Covid 19, Immunoassay Reagents & test Kits |
This new multiplex qPCR-based test screens for the SARS-CoV-2 virus and simultaneously identifies and differentiates all the new mutating COVID-19 variants.
Read More